Director/PDMR Shareholding

By

Regulatory News | 23 May, 2019

Updated : 16:40

RNS Number : 0442A
Reckitt Benckiser Group PLC
23 May 2019
 

 

                                                                                                             23 May 2019

 

RECKITT BENCKISER GROUP PLC

 DIRECTOR/PDMR SHAREHOLDINGS

 

Reckitt Benckiser Group plc (the "Company" or "RB") announces the following change in the interests of a Director in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

 

     The remuneration of RB's Non-Executive Directors includes fees which are to be used in the purchase of Shares. £125,000 of the Chairman's annual fee and £16,750 of the Non-Executive Directors' base fee (net) is invested in Shares which they are expected to retain for the duration of their tenure.   

 

   The Company was notified on 22 May 2019 that Mehmood Khan, Independent Non-Executive Director, purchased a total of 147 Shares on 22 May 2019 at a price of $81.54 per share. 

 

    The Company was further notified on 23 May 2019 that Chris Sinclair, Chairman, purchased a total of 1,076 Shares on 23 May 2019 at a price of £63.75 per share.

 

 

The following disclosures are made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mehmood Khan

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification/
Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Reckitt Benckiser Group plc

b)

LEI

5493003JFSMOJG48V108

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in Reckitt Benckiser Group plc

GB00B24CGK77

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

$81.54

147

 

d)

Aggregated information

-       Aggregated volume

-       Price

Aggregate Price

Aggregate Volume

Aggregate Total

$81.54

147

$11,986.38

 

 

e)

Date of the transaction

2019-05-22

f)

Place of the transaction

Outside a trading venue

 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

 

a)

Name

Chris Sinclair

 

 

2

Reason for the notification

 

 

a)

Position/status

Chairman

 

 

b)

Initial notification/
Amendment

Initial notification

 

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

a)

Name

Reckitt Benckiser Group plc

 

 

b)

LEI

5493003JFSMOJG48V108

 

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in Reckitt Benckiser Group plc

GB00B24CGK77

 

 

b)

Nature of the transaction

Purchase of shares

 

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£63.75

1,076

 

 

 

d)

Aggregated information

-       Aggregated volume

-       Price

Aggregate Price

Aggregate Volume

Aggregate Total

£63.75

1,076

£68,595

 

 

 

 

e)

Date of the transaction

2019-05-23

 

 

f)

Place of the transaction

London Stock Exchange, Main Market - XLON

 

     

 

For further Information:
Christine Logan

Deputy Company Secretary
Tel +44 (0) 1753 217 800

 

Richard Joyce

SVP, Investor Relations

Tel. +44 (0)1753 217 800

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

About RB

RB* is a leading global health, hygiene and home company inspired by a vision of the world where people are healthier and live better. Its purpose is to make a difference by giving people innovative solutions for healthier lives and happier homes.

Through its two business units, Health and Hygiene Home, RB has operations in over 60 countries and its products reach millions of people globally every day. Its trusted household brands include names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite and Air Wick.

RB's drive to achieve, passion to outperform and commitment to quality and scientific excellence is manifested in the work of over 40,000 diverse, talented entrepreneurs worldwide.

For more information visit www.rb.com

 

 *RB is the trading name of the Reckitt Benckiser group of companies

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBUGDUCGDBGCX

Last news